Sanofi, Astra drug approved to protect infants from RSV in Europe

[ad_1] Sanofi and AstraZeneca Plc’s Beyfortus won European approval to protect babies from respiratory syncytial virus, a common infection that can turn deadly in young children. The European Commission became the first regulatory body to approve the antibody injection, clearing it for use in all newborns before their first RSV season, Sanofi said in a… Continue reading Sanofi, Astra drug approved to protect infants from RSV in Europe